Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Stability studies of parenteral nutrition with a high dose of vitamin C.

Stawny M, Gostyńska A, Olijarczyk R, Dettlaff K, Jelińska A, Ogrodowczyk M.

J Oncol Pharm Pract. 2020 Feb 13:1078155220904438. doi: 10.1177/1078155220904438. [Epub ahead of print] No abstract available.

PMID:
32054415
2.

The Interactions between Ciprofloxacin and Parenteral Nutrition Admixtures.

Gostyńska A, Stawny M, Dettlaff K, Jelińska A.

Pharmaceutics. 2019 Dec 27;12(1). pii: E27. doi: 10.3390/pharmaceutics12010027.

3.

Stability of high-dose thiamine in parenteral nutrition for treatment of patients with Wernicke's encephalopathy.

Stawny M, Gostyńska A, Olijarczyk R, Jelińska A, Ogrodowczyk M.

Clin Nutr. 2019 Dec 11. pii: S0261-5614(19)33170-X. doi: 10.1016/j.clnu.2019.12.003. [Epub ahead of print]

PMID:
31866128
4.

Development, Validation, and Stability Assessment Application of RP-HPLC-DAD Method for Quantification of Ampicillin in Total Parenteral Nutrition Admixtures.

Stawny M, Gostyńska A, Dettlaff K, Jelińska A, Kościelniak M, Ogrodowczyk M.

Antibiotics (Basel). 2019 Dec 15;8(4). pii: E268. doi: 10.3390/antibiotics8040268.

5.

Clinical Nutrition of Critically Ill Patients in the Context of the Latest ESPEN Guidelines.

Gostyńska A, Stawny M, Dettlaff K, Jelińska A.

Medicina (Kaunas). 2019 Dec 2;55(12). pii: E770. doi: 10.3390/medicina55120770.

6.

In vitro compatibility studies of vancomycin with ready-to-use parenteral nutrition admixtures for safer clinical practice.

Stawny M, Nadolna M, Jelińska A.

Clin Nutr. 2019 Nov 15. pii: S0261-5614(19)33141-3. doi: 10.1016/j.clnu.2019.11.014. [Epub ahead of print]

PMID:
31784302
7.

Physicochemical Compatibility and Stability of Linezolid with Parenteral Nutrition.

Tomczak S, Stawny M, Dettlaff K, Kieliszek M, Słomińska D, Jelińska A.

Molecules. 2019 Mar 29;24(7). pii: E1242. doi: 10.3390/molecules24071242.

8.

Effect of Lipid Emulsion on Stability of Ampicillin in Total Parenteral Nutrition.

Stawny M, Gostyńska A, Dettlaff K, Jelińska A, Główka E, Ogrodowczyk M.

Nutrients. 2019 Mar 6;11(3). pii: E559. doi: 10.3390/nu11030559.

9.

Hepatitis C - New drugs and treatment prospects.

Zając M, Muszalska I, Sobczak A, Dadej A, Tomczak S, Jelińska A.

Eur J Med Chem. 2019 Mar 1;165:225-249. doi: 10.1016/j.ejmech.2019.01.025. Epub 2019 Jan 14. Review.

PMID:
30685524
10.

Formulation and characterization of EGCG for the treatment of superficial bladder cancer.

Dettlaff K, Stawny M, Ogrodowczyk M, Jelińska A, Bednarski W, Wątróbska-Świetlikowska D, Keck RW, Khan OA, Mostafa IH, Jankun J.

Int J Mol Med. 2017 Aug;40(2):329-336. doi: 10.3892/ijmm.2017.3024. Epub 2017 Jun 14.

11.

STUDIES OF THE CRYSTALLINE FORM OF CEFUROXIME AXETIL: IMPLICATIONS FOR ITS COMPATIBILITY WITH EXCIPIENTS.

Talaczynska A, Mizera M, Szybowicz M, Nowicka AB, Garbacki P, Paczkowska M, Zalewski P, Kozak M, Oszczapowicz I, Jelinska A, Cielecka-Piontek J.

Acta Pol Pharm. 2016 Sep;73(5):1299-1309.

PMID:
29638070
12.

New Molecular Targets of Anticancer Therapy - Current Status and Perspectives.

Zajac M, Muszalska I, Jelinska A.

Curr Med Chem. 2016;23(37):4176-4220. Review.

PMID:
27528054
13.

A SIMPLE AND-SENSITIVE STABILITY-INDICATING UHPLC-DAD METHOD FOR THE DETERMINATION OF CEFETAMET PIVOXIL HYDROCHLORIDE.

Garbacki P, Cielecka-Piontek J, Zalewski P, Oszczapowicz I, Jelińska A.

Acta Pol Pharm. 2016 May-Jun;73(3):621-6.

PMID:
27476279
14.

STABILITY OF CEFPIROME SULFATE IN AQUEOUS SOLUTIONS.

Zalewski P, Jelińska A, Paczkowska M, Garbacki P, Talaczyńska A, Stfpniak P, Cielecka-Piontek J.

Acta Pol Pharm. 2016 Jan-Feb;73(1):23-7.

PMID:
27008797
15.

Determining whether curcumin degradation/condensation is actually bioactivation (Review).

Jankun J, Wyganowska-Świątkowska M, Dettlaff K, Jelińska A, Surdacka A, Wątróbska-Świetlikowska D, Skrzypczak-Jankun E.

Int J Mol Med. 2016 May;37(5):1151-8. doi: 10.3892/ijmm.2016.2524. Epub 2016 Mar 11. Review.

PMID:
26985652
16.

Beta-Blockers: Current State of Knowledge and Perspectives.

Ogrodowczyk M, Dettlaff K, Jelinska A.

Mini Rev Med Chem. 2016;16(1):40-54. Review.

PMID:
26471965
17.

Stability of cefozopran hydrochloride in aqueous solutions.

Zalewski P, Skibiński R, Paczkowska M, Garbacki P, Talaczyńska A, Cielecka-Piontek J, Jelińska A.

Drug Dev Ind Pharm. 2016;42(4):572-7. doi: 10.3109/03639045.2015.1054834. Epub 2015 Jun 16.

PMID:
26079426
18.

Application of vibrational spectroscopy supported by theoretical calculations in identification of amorphous and crystalline forms of cefuroxime axetil.

Talaczyńska A, Lewandowska K, Jelińska A, Garbacki P, Podborska A, Zalewski P, Oszczapowicz I, Sikora A, Kozak M, Cielecka-Piontek J.

ScientificWorldJournal. 2015;2015:921049. doi: 10.1155/2015/921049. Epub 2015 Jan 11.

19.

Assay of Diastereoisomers of Cefuroxime Axetil in Amorphous and Crystalline Forms Using UHPLC-DAD.

Garbacki P, Teżyk A, Zalewski P, Jelińska A, Paczkowska M, Talczyńska A, Oszczapowicz I, Cielecka-Piontek J.

Chromatographia. 2014;77(21-22):1489-1495. Epub 2014 Oct 9.

20.

Stability of [(N-piperidine)methylene]daunorubicin hydrochloride and [(N-pyrrolidine)methylene]daunorubicin hydrochloride in solid state.

Medenecka B, Zalewski P, Kycler W, Piekarski M, Lemiech W, Oszczapowicz I, Jelińska A.

Acta Pol Pharm. 2014 May-Jun;71(3):431-8.

Supplemental Content

Loading ...
Support Center